Biomedical Nanotechnology– A Powerful Tool for Coronavirus Vaccine Development Coronaviruses such as Middle East Respiratory Syndrome Virus (MERS-CoV) mutate rapidly, so innovative vaccine technologies are needed to combat evolving viral strains. The Institute of Biomedical Sciences has adopted cuttingedge nanotechnology to develop a virus-mimicking coronavirus vaccine. This nanoparticle vaccine can effectively stimulate the immune system in animals, “For centuries our immune system has evolved against the threat of nanoparticulate viral pathogens. Nanotechnology thus offers an immense toolset for antiviral vaccine engineering.” –Che-Ming Jack Hu, Associate Research Fellow, Institute of Biomedical Sciences generating durable antibodies to up to 300 days or more, and boosting cellular immunity. In an animal model of lethal coronavirus challenge, the nanoparticle vaccine confers a 100% survival benefit. Academia Sinica’s nanoparticle vaccine technology has already received numerous international patents.
RkJQdWJsaXNoZXIy MTI2NzAzOA==